晚期非小细胞肺癌的化疗(3)
5.Rodriguez J, Pawel J,Pluzanska A, et al. A muticenter phase III study of docetaxel+cisaplatin and docetaxel+carboplatin vs vinorelbine+cisplatinin chemotherapy negative patients with advance and metastatic non-small cell lung cancer .Proc Am Soc Clin Oncol,2001;20:1252a
6.Schiller JH, Harrington D, Belani CP,et al .Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med. 2002 Jan 10;346(2):126-128.
, 百拇医药
7.Eng-Huat Tan, PJ Souquet, J Rodrigues Pereira Final results of a prospectuve randomized phase III trial comparing Vinorelbine and cisplatin(NP) versus Vinorelbine ,Ifosfamide, and cisplatin (NIP) in metastatic non-small cell lung cancer patients. Proc Am Soc Clin Oncol,2001;20:1227a.
8.Alberola V,Camps C,Provencia D ,et al.Cisaplatin/gemcitabine(CG) vs Cisaplatin/gemcitabine/ Vinorelbine(CGV) vs sequential dobulets of gemcitabine/ Vinorelbine followed by ifosfamide/vinorelbine(GV/IV) in advanced non-small cell cell lung cancer:results of a spanish lung cancer group phase III trial. Proc Am Soc Clin Oncol,2001;20:1229a.
, 百拇医药
9.Rigas J-R .Non-platinum based combination chemotherapy: phase I and II trials of docetaxel plus gemcitabine, vinorelbine, or irinotecan. Semin-Oncol. 2001 Jun; 28(3 Suppl 9): 15-20.
10.Baron F, Cueva J, Grana B,et al. Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer. Eur-J-Cancer. 2001 Jul; 37(11): 1381-1384
11.Belani C-P. Paclitaxel and docetaxel combinations in non-small cell lung cancer. Chest. 2000 Apr; 117(4 Suppl 1): 144S-151S
, 百拇医药
12.Douillard J-Y, Lerouge D, Monnier A,et al. Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study. Br-J-Cancer. 2001 May 4; 84(9): 1179-1184
13.Kosmidis P, Mylonakis N, Dimopoulos A,et al. Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: a phase III randomized study. Preliminary results. Hellenic Cooperative Oncology Group. Semin-Oncol. 2000 Feb; 27(1 Suppl 2): 3-8
, http://www.100md.com
14.Georgoulias V, Papadakis E, Alexopoulos A,et al Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial. Lancet. 2001 May 12; 357(9267): 1478-1484
15.吴一龙主编.肺癌多学科综合治疗的理论与实践.北京：人民卫生出版社，2000，213
16.Shepherd FA,Dancey,Ramlau R,et al.Prospective randomized trial of docetaxel versus best supportive care in patients with non-small cell lung cancer previously treated with platium-based chemotherapy .J Clin 2000;18:2095-2103, 百拇医药(冯卫能，吴一龙，谷力加，翁毅敏，程超)
6.Schiller JH, Harrington D, Belani CP,et al .Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med. 2002 Jan 10;346(2):126-128.
, 百拇医药
7.Eng-Huat Tan, PJ Souquet, J Rodrigues Pereira Final results of a prospectuve randomized phase III trial comparing Vinorelbine and cisplatin(NP) versus Vinorelbine ,Ifosfamide, and cisplatin (NIP) in metastatic non-small cell lung cancer patients. Proc Am Soc Clin Oncol,2001;20:1227a.
8.Alberola V,Camps C,Provencia D ,et al.Cisaplatin/gemcitabine(CG) vs Cisaplatin/gemcitabine/ Vinorelbine(CGV) vs sequential dobulets of gemcitabine/ Vinorelbine followed by ifosfamide/vinorelbine(GV/IV) in advanced non-small cell cell lung cancer:results of a spanish lung cancer group phase III trial. Proc Am Soc Clin Oncol,2001;20:1229a.
, 百拇医药
9.Rigas J-R .Non-platinum based combination chemotherapy: phase I and II trials of docetaxel plus gemcitabine, vinorelbine, or irinotecan. Semin-Oncol. 2001 Jun; 28(3 Suppl 9): 15-20.
10.Baron F, Cueva J, Grana B,et al. Gemcitabine plus vinorelbine for the treatment of advanced non-small cell lung cancer. Eur-J-Cancer. 2001 Jul; 37(11): 1381-1384
11.Belani C-P. Paclitaxel and docetaxel combinations in non-small cell lung cancer. Chest. 2000 Apr; 117(4 Suppl 1): 144S-151S
, 百拇医药
12.Douillard J-Y, Lerouge D, Monnier A,et al. Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study. Br-J-Cancer. 2001 May 4; 84(9): 1179-1184
13.Kosmidis P, Mylonakis N, Dimopoulos A,et al. Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: a phase III randomized study. Preliminary results. Hellenic Cooperative Oncology Group. Semin-Oncol. 2000 Feb; 27(1 Suppl 2): 3-8
, http://www.100md.com
14.Georgoulias V, Papadakis E, Alexopoulos A,et al Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial. Lancet. 2001 May 12; 357(9267): 1478-1484
15.吴一龙主编.肺癌多学科综合治疗的理论与实践.北京：人民卫生出版社，2000，213
16.Shepherd FA,Dancey,Ramlau R,et al.Prospective randomized trial of docetaxel versus best supportive care in patients with non-small cell lung cancer previously treated with platium-based chemotherapy .J Clin 2000;18:2095-2103, 百拇医药(冯卫能，吴一龙，谷力加，翁毅敏，程超)